Alpine Immune Sciences
(NASDAQ) ALPN
Alpine Immune Sciences Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$56.52M
Net Income (TTM)
$36.84M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ALPN News
ALPN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Alpine Immune Sciences
Industry
Biotechnology
Sector
Health CareEmployees
142
CEO
Mitchell H. Gold, MD
Website
www.alpineimmunesciences.comHeadquarters
Seattle, WA 98102, US
ALPN Financials
Key Financial Metrics (TTM)
Gross Margin
-37%
Operating Margin
-75%
Net Income Margin
-55%
Return on Equity
-13%
Return on Capital
-13%
Return on Assets
-8%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$22.03M
Operating Income
$44.25M
EBITDA
$31.41M
Operating Cash Flow
$79.01M
Capital Expenditure
$487.00K
Free Cash Flow
$79.50M
Cash & ST Invst.
$327.41M
Total Debt
$9.91M
Alpine Immune Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.03M
-25.1%
Gross Profit
$15.43M
-266.8%
Gross Margin
-2.19%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
142
N/A
Net Income
$17.92M
-62.7%
EBITDA
$22.55M
-108.8%
Quarterly Fundamentals
Net Cash
$296.01M
+62.6%
Accounts Receivable
$543.00K
-23.8%
Inventory
$0.00
+100.0%
Long Term Debt
$8.71M
-11.5%
Short Term Debt
$950.00K
-68.3%
Return on Assets
-8.47%
N/A
Return on Invested Capital
-13.10%
N/A
Free Cash Flow
$27.71M
-5.6%
Operating Cash Flow
$27.69M
-5.9%